Ali Mohamed

Ali Mohamed joined Immatics in May 2016 and is responsible for all aspects of process development and GMP manufacturing of Immatics T-cell products. Previously, Ali held CMC related roles in multiple CMOs and clinical stage biotechnology companies in the field of cell & gene therapies, including senior director of GMP manufacturing and manufacturing development at Hitachi PCT and director of GMP manufacturing and process development at AlloCure. Ali holds a PhD in Biomedical Sciences with concentration of Pharmacology from the University of Toledo and Bachelor in Pharmaceutical Sciences from the Cairo University in Egypt.